[{"address1": "455 East Medical Center Boulevard", "address2": "Suite 300", "city": "Houston", "state": "TX", "zip": "77598", "country": "United States", "phone": "281 651 5150", "website": "https://www.fibrobiologics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter  O'Heeron", "age": 59, "title": "Founder, Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 950723, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark C. Andersen C.F.A., CPA, M.B.A.", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 461877, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hamid  Khoja Ph.D.", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 423119, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ruben A. Garcia", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 10.6, "open": 10.62, "dayLow": 9.5, "dayHigh": 10.9031, "regularMarketPreviousClose": 10.6, "regularMarketOpen": 10.62, "regularMarketDayLow": 9.5, "regularMarketDayHigh": 10.9031, "volume": 78264, "regularMarketVolume": 78264, "averageVolume": 123906, "averageVolume10days": 68240, "averageDailyVolume10Day": 68240, "bid": 9.5, "ask": 10.95, "bidSize": 900, "askSize": 800, "marketCap": 327649376, "fiftyTwoWeekLow": 6.53, "fiftyTwoWeekHigh": 46.0, "fiftyDayAverage": 11.67, "twoHundredDayAverage": 11.67, "currency": "USD", "enterpriseValue": 318945376, "floatShares": 22567366, "sharesOutstanding": 32634400, "sharesShort": 6966, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0002, "heldPercentInsiders": 0.30412, "shortRatio": 0.05, "shortPercentOfFloat": 0.00029999999, "impliedSharesOutstanding": 32634400, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -19058000, "enterpriseToEbitda": -36.072, "52WeekChange": -0.42628574, "SandP52WeekChange": 0.29495108, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "FBLG", "underlyingSymbol": "FBLG", "shortName": "FibroBiologics, Inc.", "longName": "FibroBiologics, Inc.", "firstTradeDateEpochUtc": 1706797800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6752a379-a671-33c4-8602-9f32d42c8f6a", "messageBoardId": "finmb_1758633149", "gmtOffSetMilliseconds": -14400000, "currentPrice": 10.04, "recommendationKey": "none", "totalCash": 9163000, "totalCashPerShare": 0.282, "ebitda": -8842000, "totalDebt": 1888000, "quickRatio": 0.998, "currentRatio": 1.003, "debtToEquity": 150.678, "returnOnAssets": -0.66753995, "freeCashflow": 3831500, "operatingCashflow": -6401000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-17"}]